Recordati to Buy Global Rights to Sanofi's Enjaymo for $825 Million
Sanofi SA SNYNF
News
Regeneron, Sanofi Get FDA OK of Dupixent for COPD — Update
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Ventyx Biosciences Shares Rise Premarket on Sanofi Investment
Sanofi Says FDA Approves Sarclisa for Treatment of Blood Cancer Patients
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
Regeneron, Sanofi Get FDA Approval for Upper Airway Disease Treatment
Sanofi Teams Up With RadioMedix, Orano in $352 Million Deal for Cancer Therapy — Update
Sanofi Teams Up With RadioMedix, Orano Med to Develop Rare Cancer Treatment
Sanofi's Dupixent Drug Achieves Improvement for Skin Diseases
Sanofi on Track for Record High Close — Data Talk
Sanofi Multiple Sclerosis Drug Delays Disability Progression in Trial — Update
Sanofi MS Drug Meets Goal of Reducing Disability in Late-Stage Trial
5 things you need to know about COVID, flu and RSV vaccines this fall
Sanofi on Pace for Highest Close Since April 2023 — Data Talk
Vir Biotechnology to Cut 140 Jobs in Restructuring to Focus on Hepatitis Drug Development
Sanofi Raises Guidance After Profit, Sales Beat
Bain, Cinven Explore Joint Bid for Sanofi's Consumer Unit, Bloomberg Reports
Sanofi, Regeneron Get EU Approval for Dupixent to Treat Respiratory Disease
Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment
United States